CONFERENCE
Dr. GK Rath
Programme Director
Dr. Anand Mohan
Programme Deputy Director
Dr. Abhishek Shankar
Organizing Secretary
Dr. Supriya Mallick
Organizing Joint Secretary
Dr.Prabhat Malik
Joint Organizing Secretary
Dr. Sachidanand Jee Bharati
Treasure
It gives me immense pleasure to have the honour of this correspondence.
Things change, when we choose to change them. Waiting for things to happen would not beget any change. And I would like to present you an opportunity to be a part of a radical change that would bring a new lease of life to many who are yet not aware that they are headed down the wrong corridor unknowingly, unsuspectingly.
I would like to draw your attention to a grave cause which has been plaguing India and many other Low and Middle Income Countries – Cancer. In fact, there is gradual yet consistent increase in the incidence of cancer the world over. The present cancer burden is quite alarming globally and India. What is more alarming is that this figure is going to increase 50% by the year 2020 as predicted by World Health Organization.
Department of Preventive Oncology, Dr. BR Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Delhi was started with a vision idea to promote basic and clinic research in the field of clinical oncology and other related specialties/super-specialities. We organize conferences, workshops and other means of continuing medical education to assist in acquisition of knowledge skills and dissemination of information regarding new and relevant advances in the field of Clinical Oncology, and related specialties. We also organize various educational and awareness program for cancer control and prevention for general public. In order to take this initiative forward, we plan to organize “ ISCO Preceptorship Programme Non-small-cell Lung Cancer ” as a part of NCI, India educational series on 24th December 2017, presented by Indian Society of Clinical Oncology.
We solicit your support for the conference and look forward to see you.
Regards
Dr GK Rath
Professor, Department of Radiation Oncology
Chief,Dr BR Ambedkar Institute Rotary Cancer Hospital Head, NCI-India, AIIMS, Delhi
09.30 - 09.45am Welcome Address
09.45-11.00amSESSION 1 : Non-metastatic disease
| Time | Topic | Speaker |
|---|---|---|
| 09.45-10.00 | Prevention and Screening in Lung Cancer | Abhishek Shankar |
| 10.00-10.15 | An update of Radiation therapy in management of NSCLC | Supriya Mallick |
| 10.15-10.30 | Surgical approach for resectable NSCLC: An Update | Sunil Kumar |
| 10.30-10.45 | An Updates of adjuvant chemotherapy in resectable NSCLC | Ritesh Kumar |
| 10.45-11.00 | Detection of therapeutically targetable EGFR mutations in lung cancer | Deepali Jain |
11.15 - 12.00pmSession 2 : Metastatic NSCLC
| Time | Topic | Speaker |
|---|---|---|
| 11.15-11.30 | 1st line chemotherapy & targeted agents in non-driver addicted NSCLC | Ahitagni Biswas |
| 11.30-11.45 | Immunotherapy in NSCLC | Navneet Singh |
| 11.45-12.00 | Maintenance treatment: chemo maintenance or targeted agents or both? | Anant Mohan |
12.00 - 01.15pmSession 3 : Biomarker driven treatment
| Time | Topic | Speaker |
|---|---|---|
| 12.00-12.30 | T790M mutation detection changes NSCLC treatment paradigm | Prabhat Singh Malik |
| 12.30-12.45 | EGFR TKI in NSCLC - Mechanisms of resistance and new generation EGFR TKI | Manish Singhal |
| 12.45-01.00 | Tissue or liquid biopsies? For diagnosis, monitoring and early detection of resistance | CP Prasad/Mayank Singh |
| 01.00-01.30 | ALK-EML4 in NSCLC and resistance mechanism | Prabhat Singh Malik |
01.30 - 02.15pmSession 4 : Future developments
| Time | Topic | Speaker |
|---|---|---|
| 01.30-01.45 | Sequence of targeted agents and chemotherapy | Kumar Prabhash |
| 01.45-02.00 | 2nd and later lines of treatment of NSCLC | Raja Pramanik |
| 02.00-02.15 | Impact of ROS1 in the management of NSCLC | Manish Singhal |
Foyer, JLN Auditorium
Welcome Address
- Dr. G.K. Rath
Moderator
- Dr. D N Sharma
- Haresh KP
- Subhash Gupta
| S.No | Topic | Speaker |
|---|---|---|
| 1 | Radiological Anatomy | Dr Ritesh Kumar |
| 2 | Simulation Protocols | Dr Ajeet Gandhi |
| 3 | OAR Delineation | Dr Shikha Goyal |
Tea Break
Moderator
- Dr. D N Sharma
- Haresh KP
- Subhash Gupta
| S.No | Topic | Speaker |
|---|---|---|
| 1 | Nodal volume delineation in GYN malignancies | Dr Ajeet Gandhi |
| 2 | Primary Target volume delineation in Cervical Cancer | Dr Ritesh Kumar |
| 3 | Target Volume delineation in Image Based Brachy in Cervix | Dr Ajeet Gandhi |
| 4 | Brachytherapy for Challenging cases | Dr D N Sharma |
Lunch
Moderator
- Dr. D N Sharma
- Haresh KP
- Subhash Gupta
| S.No | Topic | Speaker |
|---|---|---|
| 1 | Dr Subhas Pandit | Dr Ajeet Gandhi |
| 2 | Target Volume delineation in Carcinoma Vulva | Dr Shikha Goyal |
Interaction with Participants
Chairperson
- Dr. D N Sharma
Co-ordinator
- Dr. Wineeta Melgandi
- Dr. Ravi Kanodia
Dr. Ramalingaswamy Board Room, AIIMS, New Delhi
Video Session 1: Surgery for Cancer Cervix
| S.No | Topic | Speaker |
|---|---|---|
| 1 | Laparoscopic Approach | Dr. Alka Kriplani |
| 2 | Open surgery | Dr Sunesh Kumar |
| 3 | Radical Vaginal Hysterectomy | Dr. Juhi Bharti |
Discussion
- Dr. Abha Singh
- Dr. Sunesh Kumar
Video Session 2: Surgery for Endometrial cancer
| S.No | Topic | Speaker |
|---|---|---|
| 1 | Open surgery | Dr. Jyoti Meena |
Video Session 3: Surgery for Ca Ovary
| S.No | Topic | Speaker |
|---|---|---|
| 1 | Primary Debulking Surgery | Dr.Deepika Gupta |
| 2 | Surgery for a Young Patient | Dr.Jayshree
Dr. Sunesh Kumar |
| 3 | HIPEC | Dr. M D Ray |
Lunch
Video Session 4: Surgery for Vulval Cancer
| S.No | Topic | Speaker |
|---|---|---|
| 1 | Radical Vulvectony | Dr.Seema Singhal |
| 2 | Sentinal LN Biopsy | Dr.Jyoti Meena |
Co-ordinator
- Dr. Deepika Gupta
- Dr.Jayashree Natarajan
Dept. of Biochemistry, AIIMS, New Delhi
Basics in Translational Oncology
- Dr Chandra Prakash Prasad
Instrumentation in Molecular Oncology
- Dr Debraj Singh Thoudam
PCR and its variants in diagnosis and prognosis of Gynaecological Cancers
- Dr Subhradip Karmakar
Lunch
In vitro tissue culture as a model System in gynaecological cancers.
- Dr Mayank Singh
Studying protein expression and molecular events in gynaecological cancers.
- Dr Ashok Sharma
Seminar Room, 1st Floor, Dr. BRAIRCH, AIIMS, New Delhi
Basic of palliative care
- Dr Sushma Bhatnagar
Palliative care need in Gynecological cancers
- Dr Sachidanand Jee Bharti
Cancer Pain management
- Dr Vinod Kumar
Lunch
Symptom management in Gynaecological Malignancies
| S.No | Topic | Speaker |
|---|---|---|
| 1 | Bowel obstruction, Recurrent Ascitis, Nausea & Vomiting, Constipation | Dr Nishkarsh Gupta |
| 2 | Vaginal Bleeding, Obstructive Uropathy, Lymphedema, DVT | Dr.Rakesh Garg |
| 3 | End of life care and Ethical issues | Dr Seema Mishra |
Workshop Station
- Medications
- Interventional Pain Management
- Stoma & Wound Care
- Role of Physiotherapy
Quiz Master’s
- Dr. Prashanth G
- Dr. Yousra Izzuddeen
- Dr. Srikanth Anne
Quiz prizes
- Ist Prize 30000
- 2nd Prize 20000
- 3rd Prize: 10000
Top 5 teams selection based on multiple choice questions (30 mins)
- 20 Multiple choice questions will be asked. To answer these MCQ’s 15 mins will be allotted
- Every correct answer shall be given 2 points and wrong answer shall have a negative marking of 1 point
- If multiple teams tie, selection will be based on order of registration for quiz.
Round 1 : Audio visual round (15-20 mins)
- Direct answer: 20 Points
- Wrong answer : - 10 Points
- On passing, first on buzzer gets chance.
- Correct answer: 10 Points
- Wrong answer: -5 Points
Round 2: Evidence based round (15-20 min)
- In this round two questions would be asked to each team
- Correct answer :10 Points
- Wrong answer: -5 Points
- No passing in this round
Round 3 : Connection point (20-25 min)
- Each team would be given an array of different pictures you need to connect these different pictures.
- Correct answer: 20 Points
- Wrong answer : No Points
- On passing, first on buzzer gets chance
- Correct answer: 10 Points
- Wrong answer : No Points
Round 4: Rapid fire (15 min)
- Each team will be asked a set of ten questions each. They have to answer within 120 seconds.
- Correct answer: 4 Points
- Wrong answer : No Points
- Tie breaker Round in case of a tie. QUIZ master’s decision to be final.
- These rounds are subject to change.
ABSTRACT SUBMISSION DEADLINE: 30th October, 2017
GENERAL INSTRUCTIONS
- Abstracts must be submitted by mail to: aiimsoncologyupdate@gmail.com
- For questions regarding the submission process, please e-mail antonygft@gmail.com
ABSTRACT TOPIC CATEGORIES
- Multidisciplinary management
- Innovative treatments
- Cancer Biology, HPV and molecular or immune targeting
- Supportive care, quality of life, rehabilitation, palliation
- Minimal invasive and reconstructive surgery
- Epidemiology and prevention
- Rare tumours
REGULATIONS
- With the submission of the abstract for the 1st AIIMS Oncology Update in Head and Neck Cancer conference, the first (presenting) author :
- Accepts responsibility for the accuracy of the abstract and ascertains that all authors are aware of the content before submission
- Accepts to be the contact person for all correspondence related to the abstract and to inform the co-authors about its status
- Accepts to identify any financial interest in products or processes described in the abstract. This includes stock ownership, membership on any advisory boards, commercially sponsored research or any other substantial relationships.
- Certifies that the information to be reported is for exclusive presentation in the session to which the abstract will be assigned if accepted and that the information will not be presented as such at any commercially sponsored satellite symposia during the conference
- Abstracts must be submitted and presented at the conference in English. The Scientific Committee reserves the right to reject an abstract written in poor English.
ABSTRACT SUBMISSION
- Topic category: choose the topic category that refers to the main subject of the abstract. The Scientific Committee reserves the right to re-categorise the abstract.
- Presentation preference: authors should indicate the presentation preference (oral, poster or no preference). Please note that the final decision on the presentation format rests with the Scientific Committee.
- Keywords: authors are required to provide 1 to 3 keywords (different from category).
- Title: Abstract titles should be brief and reflect the content of the abstract. The title (maximum 100 characters) is important since it focuses attention (it is the “showcase” for the presentation). Do not use capital letters in the title except for words that are always capitalised and do not use non-standard abbreviations. Body of the abstract: Abstracts should be structured in such a way as to include (1) Purpose/Objective; (2) Material/methods; (3) Results (4) Conclusion.The use of standard abbreviations is desirable. A special or unusual abbreviation must be placed (in round brackets) after the first appearance of the word for which it stands. The on-line abstract submission procedure will not accept abstracts that exceed 2500 characters (body of the abstract, excluding spaces). Authors can include one image AND one data table in the body of the abstract (this is not included in the number of characters) in JPG format. The maximum file size of each image should be 500 KB. The maximum pixel size of the image is 600(w) x 800(h) pixel.
ABSTRACT SELECTION PROCESS
- Abstracts submitted for presentation will be reviewed by a panel of experts in the field of the subject. Abstract review criteria are based on clarity, supporting data, scientific rigour, potential significance, interest in the topic chosen and innovation or usefulness.
Abstracts will be selected for one of the following presentation formats:
- Oral presentation: the abstract is selected for oral presentation at any of the proffered paper sessions.
- Poster presentation: abstracts that have been selected for presentation in a poster format. The posters are grouped by topic and are displayed throughout the meeting.
- Notification of outcome of abstract submission will be sent by email by end 30th September, 2017.